Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: LABORATOIRES THEA, 12 RUE LOUIS-BLERIOT, Z.I. DU BREZET, 63017 CLERMONT, FERRAND CEDEX 2, FRANCE
VIRGAN 0.15% w/w eye gel.
| Pharmaceutical Form |
|---|
|
Eye gel. Colourless opalescent gel. |
1 g gel contains 1.5 mg ganciclovir (0.15% w/w).
Excipient with known effect: benzalkonium chloride (75 µg/g).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ganciclovir |
Ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl)guanine or DHPG, is a broadspectrum virustatic agent which inhibits the replication of viruses, including viruses of the herpes group, both in vivo and in vitro: herpes simplex types 1 and 2 (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes zoster (HZV). |
| List of Excipients |
|---|
|
Benzalkonium chloride |
5g tube (polyethylene-aluminium) with dropper nozzle (polyethylene) and screw cap (polyethylene).
LABORATOIRES THEA, 12 RUE LOUIS-BLERIOT, Z.I. DU BREZET, 63017 CLERMONT, FERRAND CEDEX 2, FRANCE
PL 20162/0006
21/07/2000 / 20/07/2005
| Drug | Countries | |
|---|---|---|
| VIRGAN | Spain, France, Hong Kong, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
